The series begins with an exploration of how and why the methadone treatment system in the U.S. was established and a description of the service and policy landscape. 

This webinar covers methadone-related stigma, and the impact of current events such as the COVID-19 pandemic, and delves into patient and provider perspectives. 

This webinar recounts how a group of resilient drug users formed a nationwide coalition to advocate for patient-centered methadone reform, highlighting their origins, advocacy efforts, and the movement they inspired.

In partnership with R Street, NCLM members Aaron Ferguson, Paul Joudrey, and Noa Krawczyk discuss the realities of methadone diversion and access on this webinar from April 2024. For more information, check out this page. 

Learn from NCLM member Dr. Noa Krawczyk about NCLM's work to apply evidence-based research to strengthen the impact of drug policy in partnership with the Drug Policy Alliance for this webinar from April 2024. 

NCLM partnered with the Yale Program in Addiction Medicine and NYU Langone Health on March 26, 2024, to convene experts—including people with methadone experience, physicians, and policymakers from SAMHSA—to examine SAMHSA’s Final Rule on Methadone, highlighting its regulatory changes, enforcement mechanisms, and implications for treatment facilities, providers, and patients to improve access and outcomes.

NCLM partnered with several institutes to convene experts—including people with methadone experience, physicians, and policymakers from SAMHSA. The webinar explored SAMHSA’s proposed methadone regulation changes—the first in 20 years—examining their potential impact on addressing the opioid overdose crisis, expanding methadone access, and integrating perspectives from policymakers, clinicians, and individuals with lived experience.